INFLUENZA IMMUNISATION

What we know
What information do we have about the Eastern Board area?
What is the result of this on our health locally?
Policies
What is happening in the Eastern Board area?

 

Statistics
Click here for Statistics

 
Links
Click here for Links
 
Documents
Click here for Documents
What we know

Influenza (flu) can be very serious particularly for those with underlying diseases and the elderly. It is caused by flu viruses, of which there are three subtypes – A, B and C. In the UK flu is generally a winter disease with a peak in the first quarter of each year. The number of cases of flu varies considerably from year to year.

The virus that causes influenza A changes frequently, most often in small ways. If it changes to a greater extent epidemics may result because people have little immunity and if there is a very major change a large pandemic may result. In the 2003/04 flu season, a new strain was seen in Northern Ireland - Fujian Strain of Influenza A H3N2. Cases of this new strain occurred from the first week of October 2003 – several months earlier than normal. Rates of illness were highest in children under 4 years of age. The Fujian Strain predominated across the UK, Ireland and Europe during 2003/2004.

Flu vaccine is an effective measure to reduce the risk of catching flu and importantly the risk of serious complications following flu. Each year the World Health Organisation recommends the flu vaccination which should be used in the following season according to the strains which are circulating. The strains of influenza virus recommended by WHO to be included in the 2004/05 vaccine are:

an A/New Caledonia/20/99(H1N1)-like virus
an A/Fujian/411/2002(H3N2)-like virus
an B/Shanghai/361/2002-like virus
This includes the new Fujian strain.


As the protection from flu vaccination does not last long, and because of the changes to the viruses, flu vaccination needs to be given every year. Certain groups of people, who are most at risk of serious consequences of flu infection, are recommended to have annual flu vaccination. The exact groups change as new information becomes available of those at risk. (See regional policy for current recommendations). The uptake of flu vaccine in Northern Ireland was the highest in the UK in 2003/04.

Back to top

What information do we have about the Eastern Board area?

Flu vaccine is given in October/November each year in campaigns run in general practices. The Eastern Health and Social Services Board is very successful at meeting or nearly meeting the regional targets each year.

During the 2003/04 flu season 112,589 flu vaccines were administered in the Eastern Board area. In Northern Ireland a total of 270,161 vaccines were administered in the same period. The mean uptake rate as a percentage of the 65+ population in the Eastern Board was 73%, comparable to the Northern Ireland mean of 73.4%.

Back to top

What is the result of this on our health locally?

In Northern Ireland eight or nine people die directly of flu infection in an average year. Many more die each year of the complications of flu. In an epidemic year the number of deaths is much higher, and in a pandemic might be over 1000 and may be many thousands.

Admissions to hospital increase markedly in a flu epidemic mainly due to complications in the elderly.

Flu vaccine is 70-80% effective in preventing flu if the vaccine strain is a good match to the circulating strain. Flu vaccination also decreases severity of disease in those who do catch it.

Back to top

Policies

Each year, in conjunction with the Department of Health in London, the Department of Health and Social Services and Public Safety Northern Ireland issues regional guidance on the people who should be offered flu vaccination.

National policy for 2004/05 is that influenza immunisation should be offered to:

(i) All those aged 65 years and over;
(ii)

All those aged over 6 months in the following clinical risk groups:
Clinical risk category

Chronic respiratory disease,including asthma
Chronic heart disease
Chronic renal disease
Diabetes
Immunosuppression

 

(iii) those living in long-stay residential care homes or other long-stay care facilities where rapid spread is likely to follow introduction of infection and cause high morbidity and mortality (this does not include prisons, young offender institutions, university halls of
residence etc).


In 2004/05 particular attention is needed to ensure that all children in the at-risk groups are offered influenza immunisation. In addition, the Joint Committee on Vaccination and Immunisation (JCVI) have recommended that all children who have previously been admitted to hospital for lower respiratory tract disease should be included in the risk groupings for influenza and hence be offered influenza immunisation. The regional target for people over 65 is 70%. The regional target for those under 65 with an at-risk medical condition in the target groups is 60%.

Flu vaccination is also recommended for healthcare workers, as there is evidence that healthcare workers can spread influenza virus to patients in their care in settings such as GP practices, hospitals, long-term and residential care facilities and other healthcare settings. Responsibility for occupational influenza immunisation rests with the employer and it should be provided through an occupational health service. It is up to individual trusts/employers to determine their own programme and fund the immunisation of their staff.

From 2004, under the terms of the new General Medical Services contract, the influenza and pneumococcal programmes will be delivered as a Directed Enhanced Service (DES), commissioned by HSS Boards from primary medical services

Uptake of flu vaccine is reported by GPs. Surveillance of cases of flu and flu-like illness in the community is carried out by the Communicable Disease Surveillance Centre (CDSCNI) in conjunction with the Department of General Practice, Queens University Belfast. This surveillance system relies on a number of practices, across Northern Ireland, (spotter practices) reporting numbers of patients who present to them with flu-like illness, and sending samples to the Regional Virology Laboratory for testing. This information is compiled on a weekly basis and compared to previous years with the information fed back to public health and clinicians. When influenza A is circulating in the community, the DHSSPS will authorise the use of antivirals.

Back to top

What is happening in the Eastern Board area?

Flu vaccination
The flu vaccination programme in the Eastern Board area is co-ordinated by the Board and delivered in general practices and with the support of Community Trusts. The programme is supported with promotional materials produced by the Health Promotion Agency.

In 2002/03 a significant project was undertaken to examine the organisational reasons for good and poorer uptakes in GP practices. This project identified that having an identified flu co-ordinator and a good flu register were key to success.

Flu Pandemic Planning
Flu pandemics cause high rates of morbidity and mortality because of the lack of resistance in the population. There is also likely to be severe social and economic disruption.

The risk of a flu pandemic is heightened at present because of outbreaks of highly pathogenic avian flu, particularly in the Far East. There have been a number of human cases with a high mortality rate, but to date no evidence of efficient human-to-human transmission.

Work is ongoing on an international, national and local level to update and improve planning for a potential pandemic.

Pneumonoccal Immunisation Programme
Since 2002 all those aged 65 and over in Northern Ireland have been offered pneumococcal immunisation. To date it is estimated that approximately 58% of the Northern Ireland population aged 65+ have received pneumococcal immunisation. This programme is also delivered by Primary Care through a Directed Enhanced Service.

 

Back to top

 

For further information on this topic please contact us at publichealth@ehssb.n-i.nhs.uk

Eastern Health and Social Services Board Champion House, 12-22 Linenhall Street, Belfast BT2 8BS Telephone: (028) 9032 1313 Fax: (028) 9055 3681 Text Phone:(028) 9032 4980 Website: www.ehssb.org E-mail: pr@ehssb.n-i.nhs.uk
Site designed by areema.co.uk